MedTrace Logo

A Study to Evaluate the Safety and Efficacy of ExAblate Subthalomotomy for the Treatment of Parkinson's Disease Motor Features

NCT03454425 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2026-03-24

No results posted yet for this study

Summary

The objective of this study is to test the efficacy and safety of unilateral subthalamotomy performed using the ExAblate System for the treatment of Parkinson's disease (PD) motor features.

Conditions

  • Parkinson Disease

Interventions

DEVICE

Exablate Subthalamotomy

ExAblate Subthalomotomy for the Treatment of Parkinson's Disease Motor Features

DEVICE

Sham Exablate Subthalamotomy

Sham ExAblate Subthalomotomy for the Treatment of Parkinson's Disease Motor Features

Sponsors & Collaborators

  • InSightec

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-27
Primary Completion
2020-06-15
Completion
2020-06-15

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03454425 on ClinicalTrials.gov